Icahn School of Medicine at Mount Sinai
New York, 10029, United States
NCT Number: NCT06412874
The overall goal of this study is to facilitate care improvements for bladder cancer patients with locally advanced or metastatic disease by designing and evaluating a patient need assessment screening tool to be used, in the future, as standard screening measure. Adult individuals diagnosed with Stage 4 incurable locally advanced or metastatic bladder cancer will be included in this study and asked to participate in a focus group, complete a screening tool, or complete a survey. All data collected will be linked to a study ID number and HIPAA identifiers will not be linked to study data. Identifying information (ie: name, mrn, email, phone number) will be utilized for study recruitment and identifying eligible patients. Any disclosure of the human subjects' responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, educational advancement, or reputation.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Observational
New York, 10029, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will complete a screening tool survey
Time frame: 2023-2025
The Bladder Cancer Need Assessment Survey (BCNAS) includes 8 subscales: psychological, informational, care and support, logistic, sexuality, physical and daily living, communication with providers; and communication with social partners/family
All subscales scored 0-100. Full scale scored from 0- 100. Higher score mean higher levels of unmeet needs.
This is a measure of unmet needs.
Icahn School of Medicine at Mount Sinai
Other
Acronym: ACCESS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06687746
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Hodal, India
View Trial DetailsNCT06791096
Artifical Intelligence, Auscultation for Clinical Evaluation
Qinghai, China
View Trial DetailsNCT06791109
Artificial Intelligence (AI), Auscultation for Clinical Evaluation
Xining, Qinghai, China
View Trial DetailsNCT07664436
Behavior, Behavioral Symptoms
New York, United States
View Trial Details